ATE294152T1 - Substituierte tetrahydro-naphtaline und analoge verbindungen - Google Patents
Substituierte tetrahydro-naphtaline und analoge verbindungenInfo
- Publication number
- ATE294152T1 ATE294152T1 AT98951408T AT98951408T ATE294152T1 AT E294152 T1 ATE294152 T1 AT E294152T1 AT 98951408 T AT98951408 T AT 98951408T AT 98951408 T AT98951408 T AT 98951408T AT E294152 T1 ATE294152 T1 AT E294152T1
- Authority
- AT
- Austria
- Prior art keywords
- substituted tetrahydro
- naphtalines
- compounds
- analogue compounds
- naphthalenes
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 239000003814 drug Substances 0.000 abstract 2
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical class C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 abstract 2
- 206010003210 Arteriosclerosis Diseases 0.000 abstract 1
- 208000032928 Dyslipidaemia Diseases 0.000 abstract 1
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract 1
- 125000000524 functional group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C35/48—Halogenated derivatives
- C07C35/52—Alcohols with a condensed ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/18—Ethers having an ether-oxygen atom bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C43/192—Ethers having an ether-oxygen atom bound to a carbon atom of a ring other than a six-membered aromatic ring containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
- C07C49/83—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C69/757—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/94—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19741050 | 1997-09-18 | ||
| DE19832159A DE19832159A1 (de) | 1997-09-18 | 1998-07-17 | Substituierte Tetrahydro-naphthaline |
| PCT/EP1998/005874 WO1999014174A1 (de) | 1997-09-18 | 1998-09-16 | Substituierte tetrahydro-naphtaline und analoge verbindungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE294152T1 true ATE294152T1 (de) | 2005-05-15 |
Family
ID=26040079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98951408T ATE294152T1 (de) | 1997-09-18 | 1998-09-16 | Substituierte tetrahydro-naphtaline und analoge verbindungen |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6586613B1 (enExample) |
| EP (1) | EP1017659B1 (enExample) |
| JP (1) | JP2001516732A (enExample) |
| AT (1) | ATE294152T1 (enExample) |
| AU (1) | AU9744298A (enExample) |
| ES (1) | ES2242302T3 (enExample) |
| MA (1) | MA24643A1 (enExample) |
| PT (1) | PT1017659E (enExample) |
| WO (1) | WO1999014174A1 (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6642268B2 (en) | 1994-09-13 | 2003-11-04 | G.D. Searle & Co. | Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors |
| EP1340508A1 (en) | 1998-12-23 | 2003-09-03 | G.D. Searle LLC. | Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications |
| DE19935966A1 (de) * | 1999-07-30 | 2001-02-01 | Bayer Ag | Verfahren zur Reduktion von Ketoalkoholen |
| US7115279B2 (en) | 2000-08-03 | 2006-10-03 | Curatolo William J | Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| ES2333645T3 (es) | 2001-06-22 | 2010-02-25 | Bend Research, Inc. | Composiciones farmaceuticas de dispersiones de medicamentos y polimeros neutros. |
| EP1269994A3 (en) | 2001-06-22 | 2003-02-12 | Pfizer Products Inc. | Pharmaceutical compositions comprising drug and concentration-enhancing polymers |
| CA2448825C (en) | 2001-06-22 | 2009-08-11 | Pfizer Products Inc. | Pharmaceutical compositions of adsorbates of amorphous drug |
| DE10148436A1 (de) * | 2001-10-01 | 2003-04-17 | Bayer Ag | Tetrahydrochinoline |
| FR2832919B1 (fr) | 2001-12-04 | 2004-02-20 | Imv Technologies | Seringue d'injection du contenu d'une paillette pour l'insemination artificielle d'un animal ou le transfert embryonnaire |
| AU2002361811A1 (en) | 2001-12-19 | 2003-07-09 | Atherogenics, Inc. | 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders |
| BR0215240A (pt) | 2001-12-19 | 2004-10-26 | Atherogenics Inc | Derivados de calcona e seu uso no tratamento de doenças |
| CA2471639A1 (en) | 2002-01-17 | 2003-07-31 | Pharmacia Corporation | Novel alkyl/aryl hydroxy or keto thiepines. |
| ES2305434T3 (es) | 2002-02-01 | 2008-11-01 | Pfizer Products Inc. | Composiciones framaceuticas de dispersiones amorfas de farmacos y materiales que forman microfases lipofilas. |
| AR038375A1 (es) | 2002-02-01 | 2005-01-12 | Pfizer Prod Inc | Composiciones farmaceuticas de inhibidores de la proteina de transferencia de esteres de colesterilo |
| ATE407670T1 (de) | 2002-12-20 | 2008-09-15 | Pfizer Prod Inc | Dosierungsform enthaltend einen cetp-hemmer und einen hmg-coa reduktase hemmer |
| JP5546715B2 (ja) | 2003-03-17 | 2014-07-09 | 日本たばこ産業株式会社 | Ｃｅｔｐ阻害剤の医薬組成物 |
| TWI494102B (zh) * | 2003-05-02 | 2015-08-01 | Japan Tobacco Inc | 包含ｓ-〔２（〔〔１-（２-乙基丁基）環己基〕羰基〕胺基）苯基〕２-甲基丙烷硫酯及ｈｍｇ輔酶ａ還原酶抑制劑之組合 |
| CL2004001884A1 (es) | 2003-08-04 | 2005-06-03 | Pfizer Prod Inc | Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros. |
| BRPI0413277A (pt) | 2003-08-04 | 2006-10-10 | Pfizer Prod Inc | composições farmacêuticas de adsorvatos de medicamentos amorfos e materiais que formam microfases lipofìlicas |
| KR20060080214A (ko) | 2003-09-26 | 2006-07-07 | 니뽄 다바코 산교 가부시키가이샤 | 잔여 리포프로테인 생산 저해 방법 |
| DK1828137T3 (da) | 2004-12-18 | 2012-07-23 | Bayer Pharma AG | 4-Cycloalkyl-substituerede tetrahydroquinolinderivater og deres anvendelse som medikamenter |
| WO2006082518A1 (en) | 2005-02-03 | 2006-08-10 | Pfizer Products Inc. | Pharmaceutical compositions with enhanced performance |
| US7737155B2 (en) | 2005-05-17 | 2010-06-15 | Schering Corporation | Nitrogen-containing heterocyclic compounds and methods of use thereof |
| KR20080059233A (ko) | 2005-10-21 | 2008-06-26 | 노파르티스 아게 | 레닌 억제제, 및 항이상지질혈증제 및/또는 항비만제의조합물 |
| DE102006012548A1 (de) * | 2006-03-18 | 2007-09-20 | Bayer Healthcare Ag | Substituierte Chromanol-Derivate und ihre Verwendung |
| NZ587748A (en) * | 2008-03-05 | 2012-01-12 | Boehringer Ingelheim Int | Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation |
| EP2379547A1 (en) | 2008-12-16 | 2011-10-26 | Schering Corporation | Pyridopyrimidine derivatives and methods of use thereof |
| WO2010075069A1 (en) | 2008-12-16 | 2010-07-01 | Schering Corporation | Bicyclic pyranone derivatives as nicotinic acid receptor agonists |
| NZ606100A (en) | 2010-07-09 | 2014-08-29 | Daiichi Sankyo Co Ltd | Substituted pyridine compound |
| JP6742316B2 (ja) * | 2014-09-09 | 2020-08-19 | ベーリンガー インゲルハイム インターナショナル トレイディング （シャンハイ） カンパニー リミテッド | スピロ［２．５］オクタン−５，７−ジオンおよびスピロ［３．５］ノナン−６，８−ジオンの調製のための新規なプロセス |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5169857A (en) | 1988-01-20 | 1992-12-08 | Bayer Aktiengesellschaft | 7-(polysubstituted pyridyl)-hept-6-endates useful for treating hyperproteinaemia, lipoproteinaemia or arteriosclerosis |
| US5446207A (en) | 1993-09-01 | 1995-08-29 | Harbor Branch Oceanographic Institution, Inc. | Anti-dyslipidemic agents |
| HRP970330B1 (en) * | 1996-07-08 | 2004-06-30 | Bayer Ag | Cycloalkano pyridines |
-
1998
- 1998-09-08 MA MA25245A patent/MA24643A1/fr unknown
- 1998-09-16 ES ES98951408T patent/ES2242302T3/es not_active Expired - Lifetime
- 1998-09-16 US US09/508,958 patent/US6586613B1/en not_active Expired - Fee Related
- 1998-09-16 EP EP98951408A patent/EP1017659B1/de not_active Expired - Lifetime
- 1998-09-16 JP JP2000511728A patent/JP2001516732A/ja active Pending
- 1998-09-16 WO PCT/EP1998/005874 patent/WO1999014174A1/de not_active Ceased
- 1998-09-16 PT PT98951408T patent/PT1017659E/pt unknown
- 1998-09-16 AU AU97442/98A patent/AU9744298A/en not_active Abandoned
- 1998-09-16 AT AT98951408T patent/ATE294152T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999014174A1 (de) | 1999-03-25 |
| MA24643A1 (fr) | 1999-04-01 |
| ES2242302T3 (es) | 2005-11-01 |
| EP1017659A1 (de) | 2000-07-12 |
| AU9744298A (en) | 1999-04-05 |
| PT1017659E (pt) | 2005-09-30 |
| EP1017659B1 (de) | 2005-04-27 |
| US6586613B1 (en) | 2003-07-01 |
| JP2001516732A (ja) | 2001-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE294152T1 (de) | Substituierte tetrahydro-naphtaline und analoge verbindungen | |
| ID23374A (id) | Halogenopirimidin | |
| DK0741710T3 (da) | Chlorpyrimidin-mellemprodukter | |
| DK0960107T3 (da) | 6-Thiosubstituerede paclitaxeler | |
| HUP9900936A1 (hu) | Izocianátalapú készítmények, bevonatként történő alkalmazásuk és az így előállított bevonatok | |
| TR200200068T2 (tr) | Nematisital triflüorobütenler | |
| BR9612258B1 (pt) | inibidores de enzima conversora de interleucina-1beta, bem como composição farmacêutica. | |
| TR200102800T2 (tr) | Yeni bileşikler. | |
| BG103310A (en) | Benzonaphthyridins as bronchial therapeutical means | |
| DE69937301D1 (de) | Aminosterolderivate und ihre verwendungen | |
| MY120683A (en) | New phenylamidine derivatives, processes for their preparation and their use as pharmaceuticals. | |
| IL144199A0 (en) | Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions | |
| BR9713176A (pt) | Benzotiofenos amorfos,métodos de preparação e métodos de uso | |
| ATE232081T1 (de) | Orale zusammensetzung enthaltend perlit | |
| ATE165594T1 (de) | Triarylethylenderivate zur therapeutischen verwendung | |
| ID27733A (id) | Metoksiminofenilasetamida | |
| AU6832498A (en) | Substituted benzyl oximino compounds | |
| ATE265418T1 (de) | Neue substituierte 3-phenoxy- und 3- phenylalkyloxy-2-phenyl-propylamine | |
| DK1011329T3 (da) | 7-Methylthiooxomethyl- og 7-methylthiodioxomethyl-paclitaxeler | |
| ATE251619T1 (de) | 1,4-dioxacycloalkan-2-one und 1,4-dioxacycloalken-2-one | |
| ATE275551T1 (de) | Halogenpyrimidine | |
| TR199800850T2 (xx) | Kan� d�zenleyici bile�imler. | |
| DE60038735D1 (de) | Pseudomycin analoge | |
| ATE293107T1 (de) | Luminacine analoge und deren verwendung | |
| GR1001393B (el) | Παράγωγα ιμιδαζο[2,1-Β] 3] βενζαζεπίνης, συν?έσεις και μέ?οδος χρήσεως. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REN | Ceased due to non-payment of the annual fee |